TriSalus Life Sciences Inc. (NASDAQ:TLSI) is gearing up for its quarterly earnings release, with a focus on its innovative approach to oncology treatment.Here are three key insights from the upcoming financial announcement and recent company activities:- Wall Street anticipates an earnings per share (EPS) of -$0.17 and projected revenue of approximately $11.76 million.- Despite a negative price-to-earnings (P/E) ratio of -4.67, TLSI is actively engaging in investor relations events, including the Canaccord ...

Trisalus Life Sciences (NasdaqGM:TLSI) Update / Briefing November 12, 2025 10:00 AM ET Speaker4Good morning and welcome to the TriSalus Life Sciences KOL event. At this time, all attendees are in a listen-only mode. A question-and-answer session will follow the formal presentations. If you'd like to submit a question, you might do so by using the Q&A text box at the bottom of the webcast player. As a reminder, this call is being recorded, and a replay will be made available on the TriSalus website following ...